Danaher Corp Acquires PaloDEX Group

PRESS RELEASE
FOR IMMEDIATE RELEASE
PaloDEx Joins Gendex, DEXIS and ISI
Des Plaines, IL (November 13, 2009) Danaher Corporation (NYSE: DHR) today announced that it has acquired PaloDEx Holding Oy (“PaloDEx”), a leading manufacturer of dental imaging products with revenues of more than $100M in its most recent fiscal year that goes to market under the Instrumentarium Dental and SOREDEX brands. Instrumentarium Dental and SOREDEX will join Gendex, DEXIS, ISI, KaVo and Pelton & Crane as part of Danaher’s group of market-leading dental equipment companies.
Henrik Roos will remain in his position as President of the PaloDEx business, reporting to Henk van Duijnhoven, Danaher Group Executive. Danaher intends to have PaloDEx continue to operate from Tuusula, Finland and continue to develop and manufacture products in Tuusula.
“We plan to leverage our combined technology know-how and R&D capabilities to provide new and innovative technologies and products in digital dentistry with focus on software, diagnostics, and many exciting applications in orthodontics, implantology and prosthetics. We intend to continue to serve the dental markets with the existing portfolio of brands, Instrumentarium Dental, SOREDEX, Gendex, DEXIS and ISI, sold through the existing channel partners supported by our current sales and customer support teams,” said Henk van Duijnhoven.
Statements in this document that are not strictly historical, including statements regarding expectations for PaloDEx and for Danaher’s existing dental equipment businesses, anticipated synergies between PaloDEx and Danaher’s existing businesses and any other statements about managements’ future expectations, beliefs, goals, plans or prospects, may constitute forward looking statements. These are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. These factors include, among other things: general economic conditions and conditions affecting the dental equipment industry; Danaher’s ability to successfully integrate the Palodex business with Danaher’s existing businesses; and the ability to realize anticipated growth, synergies and cost savings. Additional information regarding factors that may cause actual results to differ materially from these forward-looking statements is available in Danaher’s SEC filings, including Danaher’s 2008 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the quarter ended October 2, 2009. These forward-looking statements speak only as of the date of this release and Danaher does not assume any obligation to update any forward-looking statement.